Bio-Rad Laboratories (BIO) Operating Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Operating Expenses data on file, last reported at $275.3 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $275.3 million, down 2.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (changed 0.18% YoY), and the FY2025 annual result was $1.1 billion, up 0.9% from the prior year.
• Operating Expenses declined to $275.3 million in Q1 2026 per BIO's latest filing, from $291.3 million in the prior quarter.
• Over five years, Operating Expenses peaked at $300.5 million in Q1 2023 and troughed at $244.7 million in Q3 2023.
• A 5-year average of $275.2 million and a median of $277.9 million in 2022 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses declined 14.52% in 2022, then rose 19.07% in 2024.
• A 5-year view of Operating Expenses shows it stood at $278.4 million in 2022, then slipped by 2.66% to $271.0 million in 2023, then advanced by 4.65% to $283.6 million in 2024, then advanced by 2.72% to $291.3 million in 2025, then decreased by 5.49% to $275.3 million in 2026.
• Business Quant data shows BIO's Operating Expenses at $275.3 million in Q1 2026, $291.3 million in Q4 2025, and $278.1 million in Q3 2025.